Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Lipid advanced glycosylation: pathway for lipid oxidation in vivo.

Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H.

Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6434-8.

2.

What is the effect of hyperglycemia on atherogenesis and can it be reversed by aminoguanidine?

Bucala R.

Diabetes Res Clin Pract. 1996 Feb;30 Suppl:123-30. Review.

PMID:
8964186
3.

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.

Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H.

Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9441-5.

4.

Hydroxyalkenal formation induced by advanced glycosylation of low density lipoprotein.

Al-Abed Y, Liebich H, Voelter W, Bucala R.

J Biol Chem. 1996 Feb 9;271(6):2892-6.

5.

The role of oxidative stress in the long-term glycation of LDL.

Menzel EJ, Sobal G, Staudinger A.

Biofactors. 1997;6(2):111-24.

PMID:
9259992
6.

Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study.

Sobal G, Menzel J, Sinzinger H.

Prostaglandins Leukot Essent Fatty Acids. 2000 Oct;63(4):177-86.

PMID:
11049692
7.

The role of advanced glycosylation end-products in the pathogenesis of atherosclerosis.

Makita Z, Yanagisawa K, Kuwajima S, Bucala R, Vlassara H, Koike T.

Nephrol Dial Transplant. 1996;11 Suppl 5:31-3. Review.

PMID:
9044304
8.

Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1.

Liguori A, Abete P, Hayden JM, Cacciatore F, Rengo F, Ambrosio G, Bonaduce D, Condorelli M, Reaven PD, Napoli C.

Eur Heart J. 2001 Nov;22(22):2075-84.

9.

Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits.

Palinski W, Koschinsky T, Butler SW, Miller E, Vlassara H, Cerami A, Witztum JL.

Arterioscler Thromb Vasc Biol. 1995 May;15(5):571-82.

10.

Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins.

Dimitriadis E, Griffin M, Collins P, Johnson A, Owens D, Tomkin GH.

Diabetologia. 1996 Jun;39(6):667-76.

PMID:
8781762
11.

Susceptibility of low- and high-density lipoproteins from diabetic subjects to in vitro oxidative modification.

Julier K, Mackness MI, Dean JD, Durrington PN.

Diabet Med. 1999 May;16(5):415-23.

PMID:
10342342
12.

Effect of alpha-tocopherol on LDL oxidation and glycation: in vitro and in vivo studies.

Li D, Devaraj S, Fuller C, Bucala R, Jialal I.

J Lipid Res. 1996 Sep;37(9):1978-86.

13.

Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.

Osawa T, Kato Y.

Ann N Y Acad Sci. 2005 Jun;1043:440-51. Review.

PMID:
16037265
14.
15.

Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin.

Sakata N, Moh A, Takebayashi S.

Heart Vessels. 2002 Nov;17(1):22-9.

PMID:
12434198
16.

Immunochemical detection of advanced glycosylation end products in vivo.

Makita Z, Vlassara H, Cerami A, Bucala R.

J Biol Chem. 1992 Mar 15;267(8):5133-8.

17.

[Products of advanced glycosylation and the pathogenesis of accelerated atherosclerosis in diabetes].

Basta G, De Caterina R.

G Ital Cardiol. 1996 Jun;26(6):699-719. Review. Italian.

PMID:
8803591
18.
19.

The effects of glycation/glycoxidation on the liberation of 8-epi-PGF2alpha from low density lipoprotein during its in vitro oxidation.

Sobal G, Menzel EJ, Sinzinger H.

Prostaglandins Leukot Essent Fatty Acids. 2000 Apr;62(4):217-24.

PMID:
10882185
Items per page

Supplemental Content

Write to the Help Desk